Web Analytics

Start up Profile

Ancilia Biosciences

Ancilia Biosciences United States - New York, New York
START UP

1 Disclosed Funding Rounds $4,200,000
0 Participating Investments




Ancilia is harnessing the natural power of CRISPR to develop a new class of bacterial therapies and products for a range of applications.

Capital Raised

Date Round Raised Participating Investors
August, 29 ,2024 Unknown $4,200,000